Atlas Trials

A Study to Investigate the Efficacy and Safety of RG7774 in Patients With Diabetes Mellitus Type 1 or Type 2 With Treatment-Naive Diabetic Retinopathy

Clinical trial NCT04265261 · COMPLETED

Trial details

NCT number
NCT04265261
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Diabetic Retinopathy
Start date
2020-06-05
Primary completion
2023-07-19
Enrollment
139

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.